News
- Author:
- Jim Kling
Publish date: January 12, 2022
The EXALT Model-D beats high-level disinfection of reusable devices among patients undergoing endoscopic retrograde cholangiopancreatography.
News
- Author:
- Jim Kling
Publish date: January 11, 2022
The relatively high incidence of upper GI cancer among patients with GERD suggests benefit from even one endoscopy, according to the investigators....
News
- Author:
- Jim Kling
Publish date: January 7, 2022
The screening program had no apparent effect on incidence and mortality of proximal cancers.
News
- Author:
- Jim Kling
Publish date: January 3, 2022
Both Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) are effective at improving hepatic steatosis in type 2 diabetes patie...
News
- Author:
- Jim Kling
Publish date: January 3, 2022
Black men in radiotherapy clinical trials had similar outcomes to White men.
News
- Author:
- Jim Kling
Publish date: January 3, 2022
Oropharyngeal cancer cases and mortality rates are up for older men, particularly in the Midwest and Southeast. Physicians urge HPV vaccination for...
News
- Author:
- Jim Kling
Publish date: December 29, 2021
Few eligible patients undergo CT screening despite survival benefits.
News
- Author:
- Jim Kling
Publish date: December 28, 2021
Although the sample size was small, this study showed that 4 weeks of omega-3 supplementation improved sleep quality in cancer patients.
News
- Author:
- Jim Kling
Publish date: December 22, 2021
New research reveals details on the JAK inhibitor’s pharmacokinetics, including possible targets for future research.
News
- Author:
- Jim Kling
Publish date: December 21, 2021
The relatively high incidence of upper GI cancer among patients with GERD suggests benefit from even one endoscopy, according to the investigators....
News
- Author:
- Jim Kling
Publish date: December 21, 2021
The EXALT Model-D beats high-level disinfection of reusable devices among patients undergoing endoscopic retrograde cholangiopancreatography.
News
- Author:
- Jim Kling
Publish date: December 21, 2021
Immune checkpoint inhibition plus trastuzumab and chemotherapy produced a striking response rate for patients with aggressive gastric cancer.
News
- Author:
- Jim Kling
Publish date: December 17, 2021
The screening program had no apparent effect on incidence and mortality of proximal cancers.
News
- Author:
- Jim Kling
Publish date: December 15, 2021
A tunneled peritoneal catheter drainage system relieved symptoms with an infection risk similar to standard of care.
News
- Author:
- Jim Kling
Publish date: December 13, 2021
Two small studies suggest gut microbiota changes could influence susceptibility.
